Artículos Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation Artículos Archivos adjuntos Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation 1466 descargas Temas relacionados COVID-19 Manejo en UCI Tratamientos
